SCHEMBL19236830

SCHEMBL19236830

CC(C)c1ccc(O)c(C(=O)I)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.58
HSP90AB1 P08238 2/20 0.58
TYR P14679 3/20 0.52
RNASEH1 O60930 1/20 0.52
ALDH1A1 P00352 4/20 0.50
ALOX12 P18054 2/20 0.50
HTT P42858 2/20 0.50
GAA P10253 2/20 0.50
HIF1A Q16665 2/20 0.50
TRPA1 O75762 1/20 0.47
PTGS1 P23219 1/20 0.47
CACNA1C Q13936 1/20 0.47
KDM4E B2RXH2 3/20 0.43
HPGD P15428 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
CYP2C9 P11712 3/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1649282 0.82 ALDH1A1 (0.62) HSP90AA1HSP90AB1RNASEH1ALDH1A1ALOX12
SCHEMBL29495445 0.82 HSP90AA1 (0.60) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL2354241 0.82 HSP90AA1 (0.60) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL24413664 0.81 HSP90AA1 (0.58) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL14570448 0.81 HSP90AA1 (0.58) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL19236879 0.79 HSP90AA1 (0.41) HSP90AA1HSP90AB1TYRRNASEH1HIF1A
SCHEMBL21786696 0.78 HSP90AA1 (0.55) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL27778658 0.78 HSP90AB1 (0.64) HSP90AA1HSP90AB1TYRRNASEH1ALDH1A1
SCHEMBL18557372 0.77 PTGS1 (0.47) HSP90AA1HSP90AB1RNASEH1HIF1ATRPA1
SCHEMBL19236936 0.77 HPGD (0.51) HSP90AA1HSP90AB1ALDH1A1HTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240068009-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES PROMEGA CORPORATION 2024-02-29 US disclosed
US-11781168-B2 Process for preparing substituted imidazo[1,2-α]pyrazines PROMEGA CORPORATION (US) 2023-10-10 US disclosed
US-10669568-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates PROMEGA CORPORATION (US) 2020-06-02 US disclosed
US-20190241932-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2019-08-08 US disclosed
US-9924073-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof PROMEGA CORPORATION (US) 2018-03-20 US disclosed
US-20170233789-A1 COELENTERAZINE ANALOGUES JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11781168-B2 Process for preparing substituted imidazo[1,2-α]pyrazines CYP4Z1, CYP2E1, CYP2F1 HSP90AA1 1928/4885HSP90AB1 1798/4885TYR 478/4885
US-20190241932-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 HSP90AA1 2594/4885HSP90AB1 2476/4885TYR 327/4885
US-20170233789-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 HSP90AA1 2594/4885HSP90AB1 2476/4885TYR 327/4885
US-20240068009-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES PGLS, AADAC, GLB1 HSP90AA1 2736/4885HSP90AB1 3476/4885TYR 1583/4885
US-10669568-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates AADAC, PGLS, GLB1 HSP90AA1 2801/4885HSP90AB1 3519/4885TYR 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.